Australia's medicine regulator has identified a second case of rare blood clots believed to be linked to the AstraZeneca vaccine. The blood clots affected a woman aged in her 40s who was vaccinated in Western Australia. Head of the Therapeutic Goods Administration Professor John Skerritt says despite the latest case, he wants to reassure people the odds of the rare blood clot remain low. The federal government has decided against buying the Johnson and Johnson coronavirus vaccine to boost the nation's immunisation rollout. Health Minister Greg Hunt has ruled out proceeding with the purchase at this stage because it is too similar to the AstraZeneca drug.
A lottery win 'much much much more likely' than clotting from AstraZeneca vaccine: TGA

Diretor-Geral da TGA/Administração de Produtos Terapêuticos - Therapeutic Goods Administration, o professor John Skerritt. Source: AAP
An 80-year-old man has died in Queensland after probably contracting coronavirus in the Philippines. And health officials say they have identified a possible second case of a rare blood clot linked to the AstraZeneca vaccine.
Share